Results 71 to 80 of about 14,484 (178)

Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry

Complexity
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system.
Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh   +7 more
doaj   +1 more source

Data-Driven Vaccine Clinical Trial Design Features and Associated Progress Patterns: An Analysis of 1618 Clinical Trials from 2012 to 2022

Vaccines
Background/Objectives: Vaccine clinical trials face high costs, long timelines, and variable progression rates, yet systematic evidence linking trial design features to progression outcomes remains limited.
Siyang Chan, Dachuang Zhou, Di Zhang, Yuting Xia, Wenxi Tang   +4 more
doaj   +1 more source

Cost-effectiveness of Kang Ai injection plus chemotherapy vs. Shenqi Fuzheng injection plus chemotherapy in the first-line treatment of advanced non-small cell lung cancer

Frontiers in Medicine
ObjectiveThis study aimed to evaluate the cost-effectiveness of two Chinese patent medicines, including Kang Ai injection and Shenqi Fuzheng injection with each combined with platinum-based chemotherapy as the first-line treatment for patients with ...
Junjie Zhu, Junjie Zhu, Lei Tian, Lei Tian   +3 more
doaj   +1 more source

Analysis of the knowledge and skills of physiotherapists and physiotherapy students regarding pulmonary rehabilitation in post-COVID-19 patients

BMC Medical Education
Background Pulmonary rehabilitation plays a crucial role in the recovery of patients after COVID-19. Because training standards and clinical exposure differ internationally, the present findings should be interpreted within the Polish educational and ...
Dorota Kopciuch, Krzysztof Ciosek, Kinga Adamska, Natalia Chojara, Anna Paczkowska, Tomasz Zaprutko, Piotr Ratajczak, Elżbieta Nowakowska, Krzysztof Kus   +8 more
doaj   +1 more source

Anaesthesia pharmacoeconomics [PDF]

Canadian Journal of Anaesthesia, 1993
openaire   +2 more sources

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

BMC Cancer
Objectives To compare the efficacy, safety and effects on quality of life of different ALK-inhibitors for global and Asian patients with advanced ALK-positive non-small-cell lung cancer (NSCLC).
Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang   +4 more
doaj   +1 more source

Pharmacoeconomics of chronic kidney disease

Регуляторные исследования и экспертиза лекарственных средств, 2018
A pharmacoeconomic study is a comprehensive scientific and research activity, which should take into account specific characteristics of a research subject as well as nosology based on common methodological approaches of pharmacoeconomics,.
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, G. T. Abdrashitova, M. V. Protsenko   +4 more
doaj  

Pharmacoeconomic

Bulletin of Faculty of Pharmacy Cairo University, 2014
Community-acquired pneumonia (CAP) is a serious and widespread infection due to its high incidence, morbidity, mortality and increased healthcare costs. This study aimed at investigating antibiotic combination regimen containing fluoroquinolone (Group A) and antibiotic combination regimen not containing fluoroquinolone (Group B) in terms of ...
Weiam A. Harwan, Maggie M. Abbassi, May M. El-Attar, Samar F. Farid   +3 more
openaire   +1 more source

Pharmacoeconomics [PDF]

Journal of Korean Society for Clinical Pharmacology and Therapeutics, 2008
openaire   +2 more sources

Correction: Incremental Disease Burden (Healthcare Costs and Resources) of Duchenne Muscular Dystrophy in the US: A Matched Cohort Analysis. [PDF]

Pharmacoecon Open
Scavina M, Posner N, Dorling P, Talaga A, Stachel A, Alvir J.   +5 more
europepmc   +1 more source